134 related articles for article (PubMed ID: 9586059)
1. Chiral influences of feedback inhibition with dCTP on murine deoxycytidine kinase.
Tomikawa A; Yamaguchi T; Kawaguchi T; Shudo K; Saneyoshi M
Nucleic Acids Symp Ser; 1997; (37):181-2. PubMed ID: 9586059
[TBL] [Abstract][Full Text] [Related]
2. Chiral discrimination of 2'-deoxy-L-cytidine and L-nucleotides by mouse deoxycytidine kinase: low stereospecificities for substrates and effectors.
Tomikawa A; Kohgo S; Ikezawa H; Iwanami N; Shudo K; Kawaguchi T; Saneyoshi M; Yamaguchi T
Biochem Biophys Res Commun; 1997 Oct; 239(1):329-33. PubMed ID: 9345319
[TBL] [Abstract][Full Text] [Related]
3. Nucleotide specificity of human deoxycytidine kinase.
Shewach DS; Reynolds KK; Hertel L
Mol Pharmacol; 1992 Sep; 42(3):518-24. PubMed ID: 1406603
[TBL] [Abstract][Full Text] [Related]
4. Kinetic analysis of human deoxycytidine kinase with the true phosphate donor uridine triphosphate.
Hughes TL; Hahn TM; Reynolds KK; Shewach DS
Biochemistry; 1997 Jun; 36(24):7540-7. PubMed ID: 9200705
[TBL] [Abstract][Full Text] [Related]
5. Differences in kinetic properties of pure recombinant human and mouse deoxycytidine kinase.
Johansson M; Karlsson A
Biochem Pharmacol; 1995 Jul; 50(2):163-8. PubMed ID: 7632159
[TBL] [Abstract][Full Text] [Related]
6. A pre-steady-state kinetic analysis of substrate binding to human recombinant deoxycytidine kinase: a model for nucleoside kinase action.
Turk B; Awad R; Usova EV; Björk I; Eriksson S
Biochemistry; 1999 Jun; 38(26):8555-61. PubMed ID: 10387103
[TBL] [Abstract][Full Text] [Related]
7. Direct photoaffinity-labelling of human deoxycytidine kinase with the feedback inhibitor dCTP.
Jansson O; Eriksson S
Biochem J; 1990 Jul; 269(1):201-5. PubMed ID: 2165395
[TBL] [Abstract][Full Text] [Related]
8. Hydrodynamic and spectroscopic studies of substrate binding to human recombinant deoxycytidine kinase.
Mani RS; Usova EV; Eriksson S; Cass CE
Nucleosides Nucleotides Nucleic Acids; 2003 Feb; 22(2):175-92. PubMed ID: 12744604
[TBL] [Abstract][Full Text] [Related]
9. Pyrimidine salvage enzymes in human tonsil lymphocytes: II. Purification and properties of deoxycytidine kinase.
Szyfter K; Sasvári-Székely M; Spasokukotskaja T; Antoni F; Staub M
Acta Biochim Biophys Acad Sci Hung; 1985; 20(3-4):173-82. PubMed ID: 3019066
[TBL] [Abstract][Full Text] [Related]
10. Structural basis for the preference of UTP over ATP in human deoxycytidine kinase: illuminating the role of main-chain reorganization.
Godsey MH; Ort S; Sabini E; Konrad M; Lavie A
Biochemistry; 2006 Jan; 45(2):452-61. PubMed ID: 16401075
[TBL] [Abstract][Full Text] [Related]
11. Striking ability of adenosine-2'(3')-deoxy-3'(2')-triphosphates and related analogues to replace ATP as phosphate donor for all four human, and the Drosophila melanogaster, deoxyribonucleoside kinases.
Krawiec K; Kierdaszuk B; Kalinichenko EN; Rubinova EB; Mikhailopulo IA; Eriksson S; Munch-Petersen B; Shugar D
Nucleosides Nucleotides Nucleic Acids; 2003 Feb; 22(2):153-73. PubMed ID: 12744603
[TBL] [Abstract][Full Text] [Related]
12. Kinetic studies on 2',2'-difluorodeoxycytidine (Gemcitabine) with purified human deoxycytidine kinase and cytidine deaminase.
Bouffard DY; Laliberté J; Momparler RL
Biochem Pharmacol; 1993 May; 45(9):1857-61. PubMed ID: 8494545
[TBL] [Abstract][Full Text] [Related]
13. Human deoxycytidine kinase as a deoxyribonucleoside phosphorylase.
Usova E; Maltseva T; Földesi A; Chattopadhayaya J; Eriksson S
J Mol Biol; 2004 Dec; 344(5):1347-58. PubMed ID: 15561147
[TBL] [Abstract][Full Text] [Related]
14. Kinetic properties and inhibition of human T lymphoblast deoxycytidine kinase.
Datta NS; Shewach DS; Mitchell BS; Fox IH
J Biol Chem; 1989 Jun; 264(16):9359-64. PubMed ID: 2542307
[TBL] [Abstract][Full Text] [Related]
15. Nucleoside triphosphate donors for nucleoside kinases: donor properties of UTP with human deoxycytidine kinase.
Krawiec K; Kierdaszuk B; Eriksson S; Munch-Petersen B; Shugar D
Biochem Biophys Res Commun; 1995 Nov; 216(1):42-8. PubMed ID: 7488121
[TBL] [Abstract][Full Text] [Related]
16. Selective activation of deoxycytidine kinase by thymidine-5'-thiosulphate and release by deoxycytidine in human lymphocytes.
Keszler G; Szikla K; Kazimierczuk Z; Spasokoukotskaja T; Sasvari-Szekely M; Staub M
Biochem Pharmacol; 2003 Feb; 65(4):563-71. PubMed ID: 12566083
[TBL] [Abstract][Full Text] [Related]
17. Kinetics of phosphorylation of 5-aza-2'-deoxyycytidine by deoxycytidine kinase.
Momparler RL; Derse D
Biochem Pharmacol; 1979 Apr; 28(8):1443-4. PubMed ID: 87202
[No Abstract] [Full Text] [Related]
18. Lack of enantiospecificity of human 2'-deoxycytidine kinase: relevance for the activation of beta-L-deoxycytidine analogs as antineoplastic and antiviral agents.
Verri A; Focher F; Priori G; Gosselin G; Imbach JL; Capobianco M; Garbesi A; Spadari S
Mol Pharmacol; 1997 Jan; 51(1):132-8. PubMed ID: 9016355
[TBL] [Abstract][Full Text] [Related]
19. Deoxyribonucleoside kinases belonging to the thymidine kinase 2 (TK2)-like group vary significantly in substrate specificity, kinetics and feed-back regulation.
Knecht W; Petersen GE; Munch-Petersen B; Piskur J
J Mol Biol; 2002 Jan; 315(4):529-40. PubMed ID: 11812127
[TBL] [Abstract][Full Text] [Related]
20. Differential affinities of pyrimidine nucleoside analogues for deoxythymidine and deoxycytidine kinase determine their incorporation into murine leukemia L1210 cells.
Balzarini J; De Clercq E
Acta Biochim Pol; 1987; 34(2):63-77. PubMed ID: 2823514
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
